CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer

Stock Information for Red Cat Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Red Cat Holdings Inc.

September 2025 Letter to Shareholders
CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab
CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
CytoDyn Releases ESMO Breast Cancer Meeting Poster

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.